Portfolio company
eye2gene
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deepeye Medical
This company develops artificial intelligence software that analyses eye scans to provide therapy planning support for ophthalmologists treating retinal diseases.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
Optina Diagnostics
This company develops artificial intelligence platforms and hyperspectral retinal imaging cameras to help eye specialists diagnose and manage retinal and neurodegenerative diseases.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
RhyGaze
This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.
Aireen
The company develops autonomous software that detects eye and chronic diseases from retinal scans for healthcare providers, optical stores, and screening programmes.
Amaros AI
This company develops an artificial intelligence platform for clinical trial optimisation and data analysis for ophthalmology clinics, research organisations and therapeutic teams.
